Physiogenex presents the SDT Fatty Rat at Keystone Symposia 2020

Physiogenex will be presenting its innovative SDT fatty rat model of diabetic nephropathy at the Keystone conference on Diabetes

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease - ScienceDirect

Faecal triglyceride content, respiratory quotient (RQ), voluntary

2020 Archives - Physiogenex

The Fat Mass and Obesity-Associated Protein (FTO) Regulates Locomotor Responses to Novelty via D2R Medium Spiny Neurons - ScienceDirect

Physiogenex starts collaboration with CLEA Japan, Inc.

The body produces new satiety factor during prolonged exercise – University of Copenhagen

News - Physiogenex

2020 Archives - Physiogenex

Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis

Chemogenetic Activation of Oxytocin Neurons Improves Pain in a Reserpine-induced Fibromyalgia Rat Model - ScienceDirect

Gintonin-enriched fraction protects against sarcopenic obesity by promoting energy expenditure and attenuating skeletal muscle atrophy in high-fat diet-fed mice - ScienceDirect

SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action